S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
Log in
NYSE:STE

STERIS Stock Forecast, Price & News

$189.53
+0.82 (+0.43 %)
(As of 01/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$188.25
Now: $189.53
$191.30
50-Day Range
$181.76
MA: $189.43
$202.81
52-Week Range
$105.69
Now: $189.53
$203.90
Volume401,525 shs
Average Volume499,791 shs
Market Capitalization$16.17 billion
P/E Ratio38.44
Dividend Yield0.85%
Beta0.59
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.
STERIS logo

MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

34th out of 1,928 stocks

Surgical Appliances & Supplies Industry

1st out of 41 stocks

Analyst Opinion: 2.3Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000
Employees13,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$7.83 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Market Cap$16.17 billion
Next Earnings Date2/2/2021 (Confirmed)
OptionableOptionable
$189.53
+0.82 (+0.43 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STERIS (NYSE:STE) Frequently Asked Questions

How has STERIS's stock price been impacted by COVID-19 (Coronavirus)?

STERIS's stock was trading at $145.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 30.5% and is now trading at $189.53.
View which stocks have been most impacted by COVID-19
.

Is STERIS a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than STERIS?

Wall Street analysts have given STERIS a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STERIS wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Thomas Greco's approval rating as STERIS's CEO?

538 employees have rated STERIS CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among STERIS's employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is STERIS's next earnings date?

STERIS is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for STERIS
.

How can I listen to STERIS's earnings call?

STERIS will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its quarterly earnings results on Monday, November, 2nd. The medical equipment provider reported $1.48 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.27 by $0.21. The medical equipment provider had revenue of $756.13 million for the quarter, compared to the consensus estimate of $719.54 million. STERIS had a return on equity of 14.44% and a net margin of 13.97%. The business's revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business earned $1.32 EPS.
View STERIS's earnings history
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Monday, November 2nd. Investors of record on Tuesday, November 24th will be paid a dividend of $0.40 per share on Friday, December 18th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Monday, November 23rd.
View STERIS's dividend history
.

Is STERIS a good dividend stock?

STERIS pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.85%. STERIS has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of STERIS is 28.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 23.32% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

What price target have analysts set for STE?

5 equities research analysts have issued 12-month price targets for STERIS's shares. Their forecasts range from $200.00 to $230.00. On average, they anticipate STERIS's share price to reach $210.00 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for STERIS
or view Wall Street analyst' top-rated stocks.

Who are some of STERIS's key competitors?

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are STERIS's key executives?

STERIS's management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 66, Pay $2.49M)
  • Mr. Michael J. Tokich, Sr. VP & CFO (Age 51, Pay $1.08M)
  • Mr. Daniel A. Carestio, Sr. VP & Chief Operating Officer (Age 47, Pay $1.09M)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. (Age 53, Pay $760.33k)
  • Mr. Cary L. Majors, Sr. VP of North America Commercial Operations (Age 45, Pay $690.69k)
  • Ms. Karen L. Burton, Chief Accounting Officer, VP & Controller (Age 52)
  • Julie Winter, Sr. Director of Investor Relations and Corp. Communications
  • Mr. Sudhir K. Pahwa, Sr. VP of Infection Prevention Technologies (Age 67)
  • Stephen Norton, Sr. Director of Corp. Communications
  • Mr. Renato G. Tamaro, VP & Corp. Treasurer (Age 51)

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include Frontier Capital Management Co. LLC (0.47%), Boston Trust Walden Corp (0.21%), Gateway Investment Advisers LLC (0.07%), State of Alaska Department of Revenue (0.04%), Callahan Advisors LLC (0.04%) and Fruth Investment Management (0.02%). Company insiders that own STERIS stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS
.

Which major investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Denali Advisors LLC, Crossmark Global Holdings Inc., Addenda Capital Inc., Gateway Investment Advisers LLC, and Contravisory Investment Management Inc.. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Daniel A Carestio, David B Lewis, John Adam Zangerle, Julia Madsen, Karen L Burton, Mohsen Sohi, Richard C Breeden, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS
or view top insider-selling stocks.

Which major investors are buying STERIS stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including Fruth Investment Management, Pacer Advisors Inc., State of Alaska Department of Revenue, Boston Trust Walden Corp, Kestra Advisory Services LLC, Welch & Forbes LLC, OneAscent Financial Services LLC, and Fulton Bank N.A..
View insider buying and selling activity for STERIS
or or view top insider-buying stocks.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $189.53.

How big of a company is STERIS?

STERIS has a market capitalization of $16.17 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. STERIS employs 13,000 workers across the globe.

What is STERIS's official website?

The official website for STERIS is www.steris.com.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.